Back to Search
Start Over
Rare cause of life-threatening hypercalcemia in an infant: a case report
- Source :
- Annales de Biologie Clinique, Annales de Biologie Clinique, 2022, 80 (5), TT-Cause rare d’hypercalcémie gravissime chez l’enfant : cas clinique. ⟨10.1684/abc.2022.1747⟩
- Publication Year :
- 2022
- Publisher :
- HAL CCSD, 2022.
-
Abstract
- National audience; BACKGROUND: 25-Hydroxyvitamin D 24-hydroxylase (CYP24A1) deficiency is a rare cause of autosomal recessive infantile hypercalcemia due to vitamine D hypersensitivity. CASE PRESENTATION: We report the case of a 2-year-old boy who presented with severe hypercalcemia-hypercalciuria and a bilateral nephrocalcinosis. Laboratory investigations detected a collapsed parathormone and a highly elevated 1α,25-dihydroxycholecalciferol along with an increased phosphate excretion (hypophosphatemia and hyperphosphaturia). An adapted management with two courses of palmidronic acid and an eviction of vitamin D and calcium allowed to stabilize him. A homozygous p.Leu409Ser pathogenic variant on CYP24A1 gene resulting in a collapsed 25-Hydroxyvitamin D24-hydroxylase activity was found. A normal development is possible with a meticulous clinical, biological and nutritional management and monitoring. CONCLUSIONS: Vitamin D hypersensitivity is challenging during childhood, especially due to the need to avoid vitamin D while requiring a close nutritional monitoring to maintain a normal growth. Biomarkers such as vitamin D metabolite ratio and 24,25(OH)2D3 along with ionized calcium and nutritional management can contribute to properly follow patients with vitamin D hypersensitivity.
Details
- Language :
- French
- ISSN :
- 00033898
- Database :
- OpenAIRE
- Journal :
- Annales de Biologie Clinique, Annales de Biologie Clinique, 2022, 80 (5), TT-Cause rare d’hypercalcémie gravissime chez l’enfant : cas clinique. ⟨10.1684/abc.2022.1747⟩
- Accession number :
- edsair.od......2755..196d82f8c81e7908b84a8b515aeb0c08
- Full Text :
- https://doi.org/10.1684/abc.2022.1747⟩